Related Experiment Video
Updated: Sep 7, 2025

08:56
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
11.0K
Transcriptome-Wide m6A Methylome and m6A-Modified Gene Analysis in Asthma
Deyang Sun1, Xiaolu Cai1, Fenglin Shen1
1The First Clinical College, Zhejiang Chinese Medical University, Hangzhou, China.
Frontiers in Cell and Developmental Biology
|June 17, 2022
Summary
This study identifies key N6-methyladenosine (m6A) modified genes involved in asthma, revealing potential new therapeutic targets. Understanding these RNA methylation changes offers novel insights for asthma treatment strategies.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- N6-methyladenosine (m6A) is a prevalent RNA modification regulating gene expression.
- Previous research suggests m6A regulators are involved in asthma, but specific modified genes remain unclear.
Purpose of the Study:
- To systematically evaluate the asthma methylome and identify m6A-modified genes.
- To uncover key RNA methylation-related genes in asthma pathogenesis.
Main Methods:
- Utilized methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq).
- Performed differential analysis of methylation peaks and gene expression.
- Validated findings using data from the U-BIOPRED program (87 controls, 411 asthma cases).
Main Results:
- Identified significant differences in m6A methylation peaks (416 upregulated, 152 downregulated) and gene expression (2,505 upregulated, 4,715 downregulated) in asthma.
- Screened 14 differentially expressed genes related to RNA methylation modification.
- Validated three key m6A-modified genes (BCL11A, MATK, CD300A) predominantly in exons and enriched in 3' UTR.
Conclusions:
- m6A modification plays a significant role in asthma.
- BCL11A, MATK, and CD300A are identified as key m6A-modified genes in asthma.
- Targeting these m6A-modified genes may offer novel therapeutic strategies for asthma.
Related Concept Videos
Histone Modification
13.8K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.8K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Antiasthma Drugs: Methylxanthines
390
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
390
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K

